null

SMILES: C[C@@H](C1CC1)N1Cc2cc(cc(c2C1=O)S(C)(=O)=O)-c1sc(Nc2cccc(c2)N2CCCC2=O)nc1C

InChI Key: InChIKey=BNXOEOMQSLPCKM-KRWDZBQOSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 489227   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM489227 (2-[(1S)-1-Cyclopropylethyl]-5-(4-methyl-2-{[6-(2-o...) Show SMILES C[C@@H](C1CC1)N1Cc2cc(cc(c2C1=O)S(C)(=O)=O)-c1sc(Nc2cccc(c2)N2CCCC2=O)nc1C |r| Show InChI InChI=1S/C28H30N4O4S2/c1-16-26(37-28(29-16)30-21-6-4-7-22(14-21)31-11-5-8-24(31)33)19-12-20-15-32(17(2)18-9-10-18)27(34)25(20)23(13-19)38(3,35)36/h4,6-7,12-14,17-18H,5,8-11,15H2,1-3H3,(H,29,30)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (Homo sapiens (Human))	BDBM489227 (2-[(1S)-1-Cyclopropylethyl]-5-(4-methyl-2-{[6-(2-o...) Show SMILES C[C@@H](C1CC1)N1Cc2cc(cc(c2C1=O)S(C)(=O)=O)-c1sc(Nc2cccc(c2)N2CCCC2=O)nc1C |r| Show InChI InChI=1S/C28H30N4O4S2/c1-16-26(37-28(29-16)30-21-6-4-7-22(14-21)31-11-5-8-24(31)33)19-12-20-15-32(17(2)18-9-10-18)27(34)25(20)23(13-19)38(3,35)36/h4,6-7,12-14,17-18H,5,8-11,15H2,1-3H3,(H,29,30)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.36E+3	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human))	BDBM489227 (2-[(1S)-1-Cyclopropylethyl]-5-(4-methyl-2-{[6-(2-o...) Show SMILES C[C@@H](C1CC1)N1Cc2cc(cc(c2C1=O)S(C)(=O)=O)-c1sc(Nc2cccc(c2)N2CCCC2=O)nc1C |r| Show InChI InChI=1S/C28H30N4O4S2/c1-16-26(37-28(29-16)30-21-6-4-7-22(14-21)31-11-5-8-24(31)33)19-12-20-15-32(17(2)18-9-10-18)27(34)25(20)23(13-19)38(3,35)36/h4,6-7,12-14,17-18H,5,8-11,15H2,1-3H3,(H,29,30)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [144-1102] (Homo sapiens (Human))	BDBM489227 (2-[(1S)-1-Cyclopropylethyl]-5-(4-methyl-2-{[6-(2-o...) Show SMILES C[C@@H](C1CC1)N1Cc2cc(cc(c2C1=O)S(C)(=O)=O)-c1sc(Nc2cccc(c2)N2CCCC2=O)nc1C |r| Show InChI InChI=1S/C28H30N4O4S2/c1-16-26(37-28(29-16)30-21-6-4-7-22(14-21)31-11-5-8-24(31)33)19-12-20-15-32(17(2)18-9-10-18)27(34)25(20)23(13-19)38(3,35)36/h4,6-7,12-14,17-18H,5,8-11,15H2,1-3H3,(H,29,30)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair